Literature DB >> 19135167

MUC1 mucin interacts with calcium-modulating cyclophilin ligand.

Wei Guang1, K Chul Kim, Erik P Lillehoj.   

Abstract

MUC1 is an integral membrane glycoprotein expressed on epithelial and hematopoietic cells with a COOH-terminus (CT) that mediates intracellular signal transduction. To better understand MUC1-dependent signaling, we searched for proteins binding to its CT using the yeast two-hybrid system with the MUC1 CT as bait and a human epithelial cell cDNA library as prey. Of the six positive clones identified, all encoded calcium-modulating cyclophilin ligand (CAML). The MUC1 CT interacted with CAML in transformed yeast cells as revealed by growth on selective media and in situ X-alpha-galactosidase activity. Binding of the MUC1 CT to CAML in human epithelial cells was confirmed by reciprocal coimmunoprecipitations, confocal microscopy, protein crosslinking, and coupled transcription/translation analyses. By deletion mutagenesis, the NH(2)-terminus of CAML was responsible for binding to the MUC1 CT. Finally, transfection of cells with plasmids encoding MUC1 and CAML increased intracellular calcium levels compared with cells transfected with either plasmid alone, suggesting a possible biological significance of the MUC1-CAML interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135167      PMCID: PMC3718471          DOI: 10.1016/j.biocel.2008.12.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  34 in total

1.  Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin.

Authors:  D Meerzaman; P X Xing; K C Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-03       Impact factor: 5.464

2.  Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis.

Authors:  Pinghui Feng; Junsoo Park; Bok-Soo Lee; Sun-Hwa Lee; Richard J Bram; Jae U Jung
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Episialin acts as an antiadhesive factor in an in vitro model of human endometrial-blastocyst attachment.

Authors:  J L Chervenak; N P Illsley
Journal:  Biol Reprod       Date:  2000-07       Impact factor: 4.285

4.  Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion.

Authors:  R J Quin; M A McGuckin
Journal:  Int J Cancer       Date:  2000-08-15       Impact factor: 7.396

5.  Calcium-modulating cyclophilin ligand desensitizes hormone-evoked calcium release.

Authors:  S C Tovey; M D Bootman; P Lipp; M J Berridge; R J Bram
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

6.  CAML is required for efficient EGF receptor recycling.

Authors:  David D Tran; Helen R Russell; Shari L Sutor; Jan van Deursen; Richard J Bram
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

7.  MUC1 oncoprotein promotes growth and survival of human multiple myeloma cells.

Authors:  Takeshi Kawano; Rehan Ahmad; Hiroko Nogi; Naoki Agata; Kenneth Anderson; Donald Kufe
Journal:  Int J Oncol       Date:  2008-07       Impact factor: 5.650

Review 8.  Survival and proliferation factors of normal and malignant plasma cells.

Authors:  Bernard Klein; Karin Tarte; Michel Jourdan; Karene Mathouk; Jerome Moreaux; Eric Jourdan; Eric Legouffe; John De Vos; Jean François Rossi
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

9.  Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.

Authors:  Yongqing Li; Derek Liu; Dongshu Chen; Surender Kharbanda; Donald Kufe
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

10.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  7 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

2.  Conditional deletion of calcium-modulating cyclophilin ligand causes deafness in mice.

Authors:  Elizabeth C Bryda; Nathan T Johnson; Kevin K Ohlemiller; Cynthia L Besch-Williford; Elizabeth Moore; Richard J Bram
Journal:  Mamm Genome       Date:  2011-12-15       Impact factor: 2.957

3.  Transmembrane and ubiquitin-like domain containing 1 (Tmub1) regulates locomotor activity and wakefulness in mice and interacts with CAMLG.

Authors:  Wandong Zhang; Katerina V Savelieva; Adisak Suwanichkul; Daniel L Small; Laura L Kirkpatrick; Nianhua Xu; Thomas H Lanthorn; Gui-Lan Ye
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

4.  Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line.

Authors:  Natália R Costa; Paula Paulo; Thomas Caffrey; Michael A Hollingsworth; Filipe Santos-Silva
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

5.  Effects of Bisphenol A and 4-tert-Octylphenol on Embryo Implantation Failure in Mouse.

Authors:  Dinh Nam Tran; Eui-Man Jung; Changhwan Ahn; Jae-Hwan Lee; Yeong-Min Yoo; Eui-Bae Jeung
Journal:  Int J Environ Res Public Health       Date:  2018-07-30       Impact factor: 3.390

6.  MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.

Authors:  Appolinaire A Olou; Ryan J King; Fang Yu; Pankaj K Singh
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

Review 7.  Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment.

Authors:  Yuan Li; Xiangyi Kong; Lixue Xuan; Zhongzhao Wang; Yen-Hua Huang
Journal:  J Cell Mol Med       Date:  2021-10-15       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.